|
2023 Journal Article ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation settingLee, Annemarie L., Smith, Rebecca, Burr, Lucy, Chang, Anne B., Holmes‐Liew, Chien‐Li, King, Paul, Middleton, Peter, Morgan, Lucy, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and McAleer, Rachael (2023). ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation setting. The Clinical Respiratory Journal, 17 (1), 59-69. doi: 10.1111/crj.13563 |
|
2023 Journal Article GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infectionFoo, Cheng Xiang, Bartlett, Stacey, Chew, Keng Yih, Ngo, Minh Dao, Bielefeldt-Ohmann, Helle, Jayakody Arachchige, Buddhika, Matthews, Benjamin, Reed, Sarah, Wang, Ran, Smith, Christian, Sweet, Matthew J., Burr, Lucy, Bisht, Kavita, Shatunova, Svetlana, Sinclair, Jane E., Parry, Rhys, Yang, Yuanhao, Lévesque, Jean-Pierre, Khromykh, Alexander, Rosenkilde, Mette Marie, Short, Kirsty R. and Ronacher, Katharina (2023). GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection. European Respiratory Journal, 61 (3) 2201306, 1-15. doi: 10.1183/13993003.01306-2022 |
|
2023 Journal Article Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trialsUluer, Ahmet Z, MacGregor, Gordon, Azevedo, Pilar, Indihar, Veronica, Keating, Claire, Mall, Marcus A, McKone, Edward F, Ramsey, Bonnie W, Rowe, Steven M, Rubenstein, Ronald C, Taylor-Cousar, Jennifer L, Tullis, Elizabeth, Yonker, Lael M, Chu, Chenghao, Lam, Anna P, Nair, Nitin, Sosnay, Patrick R, Tian, Simon, Van Goor, Fredrick, Viswanathan, Lakshmi, Waltz, David, Wang, Linda T, Xi, Yingmei, Billings, Joanne, Horsley, Alexander, Nash, Edward F., Bakker, Marleen, van der Meer, Renske, Merkus, Petrus ... Wilson, John (2023). Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11 (6), 550-562. doi: 10.1016/S2213-2600(22)00504-5 |
|
2022 Journal Article Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator eraDavidson, Sarah J., France, Megan, Callaway, Leonie K., Lust, Karin, Chambers, Daniel, Hopkins, Peter, Bell, Scott C., Burr, Lucy, Keating, Rebecca and Barrett, Helen L. (2022). Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. Obstetric Medicine, 16 (4), 217-221. doi: 10.1177/1753495x221146342 |
|
2022 Journal Article Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence TaskforceWhite, Heath, McDonald, Steve J, Barber, Bridget, Davis, Joshua, Burr, Lucy, Nair, Priya, Mukherjee, Sutapa, Tendal, Britta, Elliott, Julian, McGloughlin, Steven and Turner, Tari (2022). Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce. Medical Journal of Australia, 217 (7), 368-378. doi: 10.5694/mja2.51718 |
|
2022 Journal Article Carriage and transmission of macrolide resistance genes in patients with chronic respiratory conditions and their close contactsWang, Yiming, Taylor, Steven L., Choo, Jocelyn M., Papanicolas, Lito E., Keating, Rebecca, Hindmarsh, Kate, Thomson, Rachel M., Morgan, Lucy, Rogers, Geraint B. and Burr, Lucy D. (2022). Carriage and transmission of macrolide resistance genes in patients with chronic respiratory conditions and their close contacts. Chest, 162 (1), 56-65. doi: 10.1016/j.chest.2022.01.045 |
|
2022 Journal Article Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung diseaseRigauts, Charlotte, Aizawa, Juliana, Taylor, Steven L., Rogers, Geraint B., Govaerts, Matthias, Cos, Paul, Ostyn, Lisa, Sims, Sarah, Vandeplassche, Eva, Sze, Mozes, Dondelinger, Yves, Vereecke, Lars, Van Acker, Heleen, Simpson, Jodie L., Burr, Lucy, Willems, Anne, Tunney, Michael M., Cigana, Cristina, Bragonzi, Alessandra, Coenye, Tom and Crabbé, Aurélie (2022). Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. European Respiratory Journal, 59 (5) 2101293, 1-16. doi: 10.1183/13993003.01293-2021 |
|
2022 Journal Article Assessment of long-term macrolide exposure on the oropharyngeal microbiome and macrolide resistance in healthy adults and consequences for onward transmission of resistanceBurr, Lucy D., Taylor, Steven L., Richard, Alyson, Schreiber, Veronika, Lingman, Stevie, Martin, Megan, Papanicolas, Lito E., Choo, Jocelyn M. and Rogers, Geraint B. (2022). Assessment of long-term macrolide exposure on the oropharyngeal microbiome and macrolide resistance in healthy adults and consequences for onward transmission of resistance. Antimicrobial Agents and Chemotherapy, 66 (4) e02246-21. doi: 10.1128/aac.02246-21 |
|
2022 Journal Article Targeting the P2Y13 receptor suppresses IL-33 and HMGB1 release and ameliorates experimental asthmaWerder, Rhiannon B., Ullah, Md Ashik, Rahman, Muhammed Mahfuzur, Simpson, Jennifer, Lynch, Jason P., Collinson, Natasha, Rittchen, Sonja, Rashid, Ridwan B., Sikder, Md Al Amin, Handoko, Herlina Y., Curren, Bodie F., Sebina, Ismail, Hartel, Gunter, Bissell, Alec, Ngo, Sylvia, Yarlagadda, Tejasri, Hasnain, Sumaira Z., Lu, Wenying, Sohal, Sukhwinder S., Martin, Megan, Bowler, Simon, Burr, Lucy D., Martinez, Laurent O., Robaye, Bernard, Spann, Kirsten, Ferreira, Manuel A. R. and Phipps, Simon (2022). Targeting the P2Y13 receptor suppresses IL-33 and HMGB1 release and ameliorates experimental asthma. American Journal of Respiratory and Critical Care Medicine, 205 (3), 300-312. doi: 10.1164/rccm.202009-3686oc |
|
2021 Conference Publication The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway diseaseRigauts, Charlotte, Aizawa, Juliana, Taylor, Steven, Rogers, Geraint, Govaerts, Matthias, Cos, Paul, Ostyn, Lisa, Sims, Sarah, Vandeplassche, Eva, Sze, Mozes, Dondelinger, Yves, Vereecke, Lars, Van Acker, Heleen, Simpson, Jodie, Burr, Lucy, Willems, Anne, Tunney, Michael, Cigana, Cristina, Bragonzi, Alessandra, Coenye, Tom and Crabbe, Aurelie (2021). The commensal bacterium Rothia mucilaginosa has anti-inflammatory properties in vitro and in vivo, and negatively correlates with sputum pro-inflammatory markers in chronic airway disease. European-Respiratory-Society (ERS) International Congress, Thessaloniki Greece, Sep 26-30, 2021. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2021.PA873 |
|
2020 Journal Article The cystic fibrosis gut as a potential source of multidrug resistant pathogensTaylor, Steven L., Leong, Lex E. X., Sims, Sarah K., Keating, Rebecca L., Papanicolas, Lito E., Richard, Alyson, Mobegi, Fredrick M., Wesselingh, Steve, Burr, Lucy D. and Rogers, Geraint B. (2020). The cystic fibrosis gut as a potential source of multidrug resistant pathogens. Journal of Cystic Fibrosis, 20 (3), 413-420. doi: 10.1016/j.jcf.2020.11.009 |
|
2020 Journal Article Improving antenatal asthma management: a complex journeyChen, Clarissa, Meng-Wong Taing, Burr, Lucy, Barrett, Helen L. and Clifton, Vicki L. (2020). Improving antenatal asthma management: a complex journey. EMJ Respiratory, 97-107. doi: 10.33590/emjrespir/20-00143 |
|
2020 Conference Publication CARRIAGE AND TRANSMISSION OF MACROLIDE RESISTANCE GENES IN PATIENTS WITH CHRONIC LUNG DISEASESWang, Y., Taylor, S., Basham, J., Keating, R., Hindmarsh, K., Choo, J., Wesselingh, S., Burr, L. and Rogers, G. (2020). CARRIAGE AND TRANSMISSION OF MACROLIDE RESISTANCE GENES IN PATIENTS WITH CHRONIC LUNG DISEASES. HOBOKEN: WILEY. |
|
2020 Journal Article Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasisRamsey, Kathryn A., Chen, Alice C. H., Radicioni, Giorgia, Lourie, Rohan, Martin, Megan, Broomfield, Amy, Sheng, Yong H., Hasnain, Sumaira Z., Radford-Smith, Graham, Simms, Lisa A., Burr, Lucy, Thornton, David J., Bowler, Simon D., Livengood, Stephanie, Ceppe, Agathe, Knowles, Michael R., Noone, Peadar G., Donaldson, Scott H., Hill, David B., Ehre, Camille, Button, Brian, Alexis, Neil E., Kesimer, Mehmet, Boucher, Richard C. and McGuckin, Michael A. (2020). Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 201 (6), 661-670. doi: 10.1164/rccm.201906-1219OC |
|
2020 Conference Publication Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infectionHasnain, S., Wang, R., Taylor, S., Wong, K. Y., Moniruzzaman, M., Upham, J., Spann, K., Mcguckin, M. A., Burr, L. and Phipps, S. (2020). Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC, Australia, 27–31 March 2020. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13777 |
|
2019 Journal Article Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?Visser, Simone K., Bye, Peter T. P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?. Lung, 197 (6), 803-810. doi: 10.1007/s00408-019-00280-x |
|
2019 Journal Article Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysisChalmers, James D, Boersma, Wim, Lonergan, Mike, Jayaram, Lata, Crichton, Megan L, Karalus, Noel, Taylor, Steven L, Martin, Megan L, Burr, Lucy D, Wong, Conroy and Altenburg, Josje (2019). Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respiratory Medicine, 7 (10), 845-854. doi: 10.1016/s2213-2600(19)30191-2 |
|
2019 Journal Article The impact of CFTR modulator therapies on CF airway microbiologyRogers, Geraint B., Taylor, Steven L., Hoffman, Lucas R. and Burr, Lucy D. (2019). The impact of CFTR modulator therapies on CF airway microbiology. Journal of Cystic Fibrosis, 19 (3), 359-364. doi: 10.1016/j.jcf.2019.07.008 |
|
2019 Journal Article Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registryVisser, Simone K., Bye, Peter T.P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registry. Respiratory Medicine, 155, 97-103. doi: 10.1016/j.rmed.2019.07.016 |
|
2019 Journal Article Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung diseaseTong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006 |
